TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Nucleic Acids where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Nucleic Acids technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nucleic Acids

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Nucleic Acids industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleic Acids industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleic Acids industry

Treatment Of Cancer By Manipulation Of Commensal MicrofloraTHE UNIVERSITY OF CHICAGOJul 16, 2025HGF
Diagnosis Of Inflammatory Bowel Disease Based On GenesCEDARS SINAI MEDICAL CENTERMay 6, 2025ZWICKER SCHNAPPAUF & PARTNER
Guide Rna With Chemical ModificationsAGILENTJan 24, 2025KRAUS & LEDERER PARTGMBB
Guide Rna With Chemical ModificationsAGILENTJan 22, 2025DORRIES
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF
Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIESOct 30, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses ThereforTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 16, 2024STRAWMAN
Guide Rna With Chemical ModificationsAGILENTSep 23, 2024JAMES POOLE
Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIESAug 22, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
Compositions And Methods For Synthesizing 5'-Capped RnasTRILINK BIOTECHNOLOGIESAug 22, 2024COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

To stay ahead in the competitive Nucleic Acids industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleic Acids industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
Dec 1, 2021Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNATX10
May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX9
Apr 24, 2024Guide Rna With Chemical ModificationsAGILENT4
Oct 3, 2018Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA4
Jul 1, 2020Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS3
Dec 2, 2020Further Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS3
Jul 5, 2017Novel Lipid Formulations For Nucleic Acid DeliveryPROTIVA BIOTHERAPEUTICS2
May 8, 2019Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting TreatmentsTHE GENERAL HOSPITAL2
Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type XiiBECTON DICKINSON INFUSION THERAPY SYSTEMS2